Bionano Genomics Inc (BNGO)

Bionano Genomics Inc Azioni (BNGO) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	15.06% 10.72	9.318	8.662	7.415	8.215
Cost Of Revenue	26.09% 8.283	6.569	6.354	5.345	6.41
Gross Profit	11.31% 2.438	2.749	2.308	2.07	1.805
Operating Expenses	76.38% 27.39	115.96	41.55	39.91	39.33
Interest Income/Expense	6,799% 4.898	0.071	0.074	0.076	0.075
Benefits Costs and Expenses	55.15% 54.65	121.84	47.54	44.51	45.09
Costs And Expenses	76.38% 27.39	115.96	41.55	39.91	39.33
Operating Income/Loss	77.96% -24.95	-113.21	-39.24	-37.84	-37.53
Nonoperating Income/Loss	2,870% -18.97	0.685	0.359	0.745	0.655
Income/Loss From Continuing Operations Before Tax	60.96% -43.93	-112.53	-38.88	-37.10	-36.87
Income Tax Expense/Benefit	192.31% -0.036	0.039	0.033	0.026	1.805
Income/Loss From Continuing Operations After Tax	61.01% -43.89	-112.57	-38.91	-37.12	-38.68
Net Income/Loss	61.01% -43.89	-112.57	-38.91	-37.12	-38.68
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	94.56% 1.904	35.00	31.50	302.05	2.581
Diluted Average Shares	94.56% 1.904	35.00	31.50	302.05	2.581
Basic Earnings Per Share	70.19% -0.96	-3.22	-1.24	-0.12	-0.13
Diluted Earnings Per Share	70.19% -0.96	-3.22	-1.24	-0.12	-0.13
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-